tiprankstipranks
Eli Lilly & Co (DE:LLY)
XETRA:LLY

Eli Lilly & Co Stock Price & Analysis

0 Followers

LLY Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range― - ―
Previous Close€325.4
Volume393.00
Average Volume (3M)765.00
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€2.57B
Total Debt (Recent Filing)€14.70B
P/E Ratio58.6
Beta0.53
Next EarningsNov 01, 2022
Dividend Yield3.79 (1.17%)
EPS (TTM)5.56
Shares Outstanding950,174,817
R-Squared0.00624
Standard Deviation0.08
10 Day Avg. Volume1,833
30 Day Avg. Volume765
P/B Ratio-108.00
P/S Ratio13.87
P/CF Ratio41.30
P/FCF Ratio249.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside14.56% Upside
Rating ConsensusStrong Buy
Alpha0.03
Number of Analyst Covering10


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

LLY FAQ

What was Eli Lilly & Co’s price range in the past 12 months?
Currently, no data Available
What is Eli Lilly & Co’s market cap?
Currently, no data Available
When is Eli Lilly & Co’s upcoming earnings report date?
Eli Lilly & Co’s upcoming earnings report date is Nov 01, 2022 which is in 27 days.
    How were Eli Lilly & Co’s earnings last quarter?
    Eli Lilly & Co released its earnings results on Aug 04, 2022. The company reported €1.254 earnings per share for the quarter, missing the consensus estimate of €1.706 by -€0.451.
      Is Eli Lilly & Co overvalued?
      According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Eli Lilly & Co pay dividends?
        Eli Lilly & Co pays a Quarterly dividend of €1 which represents an annual dividend yield of 1.17%. Eli Lilly & Co’s last Quarterly dividend payment was on Sep 09, 2022. Eli Lilly & Co’s upcoming ex-dividend date is Aug 12, 2022
          What is Eli Lilly & Co’s EPS estimate?
          Eli Lilly & Co’s EPS estimate is €1.93.
            How many shares outstanding does Eli Lilly & Co have?
            Eli Lilly & Co has 950,174,800 shares outstanding.
              What happened to Eli Lilly & Co’s price movement after its last earnings report?
              Eli Lilly & Co reported an EPS of €1.254 in its last earnings report, missing expectations of €1.706. Following the earnings report the stock price went down -3.596%.
                Which hedge fund is a major shareholder of Eli Lilly & Co?
                Among the largest hedge funds holding Eli Lilly & Co’s share is PRIMECAP Management Co. It holds Eli Lilly & Co’s shares valued at 9B.

                  ---

                  Eli Lilly & Co Stock Analysis

                  Smart ScoreOutperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  9
                  The Eli Lilly & Co Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Eli Lilly & Co

                  Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Johnson & Johnson
                  Pfizer
                  Merck & Company
                  Bristol Myers
                  Zoetis

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis